053950 — Kyung Nam Pharm Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
KR₩65bn
Enterprise Value
KR₩50bn
Revenue
KR₩56bn

Annual balance sheet for Kyung Nam Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	23,248	45,478	35,013	50,814	51,139
Net Total Accounts Receivable
Net Total Receivables	16,451	13,945	19,443	14,360	15,399
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	54,920	77,329	71,198	77,825	79,455
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	33,852	31,235	46,710	32,327	35,068
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	125,307	138,269	166,609	166,584	155,630
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	25,411	43,887	66,933	46,279	46,236
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	52,778	44,498	87,248	51,361	47,331
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	72,529	93,771	79,362	115,223	108,300
Total Liabilities & Shareholders' Equity	125,307	138,269	166,609	166,584	155,630
Total Common Shares Outstanding